Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Trimaran Capital Partners is a private equity firm based in New York City. The firm specializes in buyouts, growth equity investments, and recapitalizations of middle-market companies, primarily in North America. Trimaran Capital Partners traces its origins to 1990, when it was established as The Argosy Group L.P. by Jay Bloom, Andrew Heyer, and Dean Kehler. The firm has managed multiple private equity funds and focused on sectors including consumer products, healthcare, and business services. Trimaran has also made investments in Israeli companies.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Trimaran Capital Partners' most recent investment?
- Trimaran Capital Partners' most recent investment was in Optimata, a personalized oncology treatment company, in February 2008.
- Which sectors does Trimaran Capital Partners focus on for investments?
- Trimaran Capital Partners has invested in the Health Tech & Life Sciences sector, with Optimata being a notable portfolio company in this area.
- Can you name a key portfolio company for Trimaran Capital Partners?
- A key portfolio company for Trimaran Capital Partners is Optimata, which focuses on personalized oncology treatment.
- What stage of funding does Trimaran Capital Partners typically participate in?
- Trimaran Capital Partners has participated in A Round funding, as seen with their investment in Optimata.
- What is the typical investment range for Trimaran Capital Partners?
- Trimaran Capital Partners' investment range is between $1.5M and $1.5M.
- When was Trimaran Capital Partners founded?
- Trimaran Capital Partners was created in 2019, according to startupim data.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1990 |
|---|